Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04096248 · ClinicalTrials.gov registry record
CT (Computerized Tomography) for Late EndovasculAr Reperfusion
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 2,790
- Enrollment target
NCT04096248: Completed study, sponsored by Boston Medical Center.
NCT04096248 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 2,790 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04096248 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 2,790 participants
- Enrollment target
Study Summary
The objective of this multicenter, retrospective, cross-sectional, chart review study is to compare outcomes (disability, complications and mortality) of patients with large vessel occlusion stroke presenting at late time window selected by either Non-Contrast CT (NCCT) only, advanced imaging with CTP (Computed Tomography Perfusion), MRI (Magnetic Resonance Imaging), or medical management. Boston Medical Center (BMC) will serve as the main data coordinating site. Fifteen additional sites will seek local IRB approval or ethics approval. The aggregated de-identified data will be analyzed comparing types of interventions and outcomes by type of imaging or medical management.
Primary Outcome
The Modified Rankin Score (mRS) is a 6 point disability scale with possible scores ranging from 0 to 5. Lower scores correlate with less disability/dependence.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,790 participants |
| Start Date | 2020-02-15 |
| Est. Completion | 2022-05-01 |
What the finished NCT04096248 record still lists
NCT04096248 is an observational study that tracks outcomes without assigning an intervention. Its 2,790 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04096248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04096248 about?
NCT04096248 is a clinical study titled "CT (Computerized Tomography) for Late EndovasculAr Reperfusion". The objective of this multicenter, retrospective, cross-sectional, chart review study is to compare outcomes (disability, complications and mortality) of patients with large vessel occlusion stroke presenting at late time window selected by either Non-Contrast CT (NCCT) only, advanced imaging with C...
What is the current status of trial NCT04096248?
This trial is currently completed. The enrollment target is 2,790 participants. The study started on 2020-02-15. Estimated completion is 2022-05-01.
Who is sponsoring clinical trial NCT04096248?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI